Msb recovering. Cynata looking well cheap at this market cap. Back to a footrace between these two given msb setbacks imho.
Ann: Approval of Clinical Trial of CYP-001 in Kidney Transplant, page-6
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.045(17.3%) |
Mkt cap ! $54.78M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 31.5¢ | 26.5¢ | $35.96K | 122.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12995 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 10185 | 1 |
View Market Depth
| Last trade - 15.59pm 18/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |